Search research articles
Contact Us
Filters
Showing results (21-30 of 232) with videos related to
Page
of 24
Sort By:
Circulation
|
December 20, 2017
Response by Hess and Hiatt to Letter Regarding Article, "A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative"
Connie N Hess, William R Hiatt
JAMA
|
June 4, 2018
Antithrombotic Therapy for Peripheral Artery Disease in 2018
Connie N Hess, William R Hiatt
The American Journal of Medicine
|
January 29, 2002
Current medical therapies for patients with peripheral arterial disease: a critical review
Judith G Regensteiner, William R Hiatt
Vascular Medicine (London, England)
|
February 10, 2007
Review of mortality and cardiovascular event rates in patients enrolled in clinical trials for claudication therapies
Eric P Brass, William R Hiatt
Vascular Medicine (London, England)
|
May 4, 2006
Masterclass series in peripheral arterial disease. Antiplatelet therapy for peripheral arterial disease and claudication
William R Hiatt, Mori J Krantz
Journal of the American College of Cardiology
|
March 7, 2006
Peripheral arterial disease in patients with diabetes
Steven P Marso, William R Hiatt
JAMA Internal Medicine
|
May 8, 2013
Two new drugs for homozygous familial hypercholesterolemia: managing benefits and risks in a rare disorder
Robert J Smith, William R Hiatt
Circulation
|
August 30, 2017
Aspirin Monotherapy Should Not Be Recommended for Cardioprotection in Patients With Symptomatic Peripheral Artery Disease
Eric P Brass, William R Hiatt
Vascular Medicine (London, England)
|
June 15, 2019
Lost in translation: Why 'lost to follow-up' matters
Connie N Hess, William R Hiatt
Journal of the American College of Cardiology
|
May 6, 2017
The Treatment Gap in Peripheral Artery Disease
William R Hiatt, R Kevin Rogers
Page
of 24
Search research articles
Search
Showing results (21-30 of 232) with videos related to
Sort By:
Page
of 24
Circulation
|
December 20, 2017
Response by Hess and Hiatt to Letter Regarding Article, "A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative"
Connie N Hess, William R Hiatt
JAMA
|
June 4, 2018
Antithrombotic Therapy for Peripheral Artery Disease in 2018
Connie N Hess, William R Hiatt
The American Journal of Medicine
|
January 29, 2002
Current medical therapies for patients with peripheral arterial disease: a critical review
Judith G Regensteiner, William R Hiatt
Vascular Medicine (London, England)
|
February 10, 2007
Review of mortality and cardiovascular event rates in patients enrolled in clinical trials for claudication therapies
Eric P Brass, William R Hiatt
Vascular Medicine (London, England)
|
May 4, 2006
Masterclass series in peripheral arterial disease. Antiplatelet therapy for peripheral arterial disease and claudication
William R Hiatt, Mori J Krantz
Journal of the American College of Cardiology
|
March 7, 2006
Peripheral arterial disease in patients with diabetes
Steven P Marso, William R Hiatt
JAMA Internal Medicine
|
May 8, 2013
Two new drugs for homozygous familial hypercholesterolemia: managing benefits and risks in a rare disorder
Robert J Smith, William R Hiatt
Circulation
|
August 30, 2017
Aspirin Monotherapy Should Not Be Recommended for Cardioprotection in Patients With Symptomatic Peripheral Artery Disease
Eric P Brass, William R Hiatt
Vascular Medicine (London, England)
|
June 15, 2019
Lost in translation: Why 'lost to follow-up' matters
Connie N Hess, William R Hiatt
Journal of the American College of Cardiology
|
May 6, 2017
The Treatment Gap in Peripheral Artery Disease
William R Hiatt, R Kevin Rogers
Page
of 24